Pierre‐Paul Bringuier

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 984 citations

Medicine, Molecular Medicine, Oncology +11

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Françoise Ducimetière, A. Lurkin, Dominique Ranchère‐Vince et al. · PLoS ONE · 2011 · 546 citations · Full text

Medicine, Oncology, Pathology +17

<i>BRAF</i>Mutation Status in Gastrointestinal Stromal Tumors

Isabelle Hostein, Nicolas Faur, Charlotte Primois et al. · American Journal of Clinical Pathology · 2009 · 229 citations

Medicine, Genetics, Oncology +17

<i>KIT</i> and <i>PDGFRA</i> Mutations and the Risk of GI Stromal Tumor Recurrence

Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida et al. · Journal of Clinical Oncology · 2015 · 173 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Role of E Boxes in the Repression of E-Cadherin Expression

Laurence A. Giroldi, Pierre‐Paul Bringuier, M. De Weijert et al. · Biochemical and Biophysical Research Communications · 1997 · 136 citations

Life Sciences, Cell Biology, Molecular Biology +7